General Information of Drug-Metabolizing Enzyme (DME ID: DME0156)
DME Name Hexosephosphate aminotransferase 2 (GFPT2), Homo sapiens DME Info
UniProt ID
GFPT2_HUMAN
EC Number    EC: 2.6.1.16     (Click to Show/Hide the Complete EC Tree)
Transferase
Transaminase
Transaminase
EC: 2.6.1.16
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2B30 Lymphoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Lymphoma Significant hypermethylation
Interaction Name DNMT-GFPT2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 3.43E-27; delta-beta: 5.56E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the GFPT2 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Hexosephosphate aminotransferase 2. As a result, the interaction between DNMT and GFPT2 can significantly affect the drug-metabolizing process of Hexosephosphate aminotransferase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B71 Gastric cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Gastric cancer Moderate hypermethylation
Interaction Name DNMT-GFPT2 interaction
The Methylation Level of Disease Section Compare with the Adjacent Tissue Moderate hypermethylation
p-value: 5.38E-37; delta-beta: 2.61E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the GFPT2 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Hexosephosphate aminotransferase 2. As a result, the interaction between DNMT and GFPT2 can moderatly affect the drug-metabolizing process of Hexosephosphate aminotransferase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.